Alpharma Pharms Drug Patent Portfolio

Alpharma Pharms owns 1 orange book drug protected by 9 US patents Given below is the list of Alpharma Pharms's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8623418 Pharmaceutical composition 07 Nov, 2029
Active
US7815934 Sequestering subunit and related compositions and methods 12 Dec, 2027
Active
US7682633 Pharmaceutical composition 19 Jun, 2027
Active
US7682634 Pharmaceutical compositions 19 Jun, 2027
Active
US8158156 Abuse-deterrent multi-layer pharmaceutical composition comprising an opioid antagonist and an opioid agonist 19 Jun, 2027
Active
US8846104 Pharmaceutical compositions for the deterrence and/or prevention of abuse 19 Jun, 2027
Active
US8877247 Abuse-deterrent multi-layer pharmaceutical composition comprising an opioid antagonist and an opioid agonist 19 Jun, 2027
Active
US8685443 Sequestering subunit and related compositions and methods 03 Jul, 2025
Active
US8685444 Sequestering subunit and related compositions and methods 03 Jul, 2025
Active


Given below is the list of recent legal activities going on the following drug patents of Alpharma Pharms.

Activity Date Patent Number
Patent litigations
Expire Patent 20 May, 2024 US8158156
Maintenance Fee Reminder Mailed 04 Dec, 2023 US8158156
Expire Patent 12 Dec, 2022 US8877247
Expire Patent 21 Nov, 2022 US7815934 (Litigated)
Expire Patent 07 Nov, 2022 US8846104
Maintenance Fee Reminder Mailed 27 Jun, 2022 US8877247
Maintenance Fee Reminder Mailed 06 Jun, 2022 US7815934 (Litigated)
Maintenance Fee Reminder Mailed 23 May, 2022 US8846104
Expire Patent 25 Apr, 2022 US7682633 (Litigated)
Expire Patent 25 Apr, 2022 US7682634 (Litigated)
Maintenance Fee Reminder Mailed 08 Nov, 2021 US7682633 (Litigated)
Maintenance Fee Reminder Mailed 08 Nov, 2021 US7682634 (Litigated)
Payment of Maintenance Fee, 8th Year, Large Entity 16 Sep, 2019 US8158156
Payment of Maintenance Fee, 4th Year, Large Entity 13 Apr, 2018 US8877247
Payment of Maintenance Fee, 8th Year, Large Entity 13 Mar, 2018 US7815934 (Litigated)


Alpharma Pharms's Family Patents

Alpharma Pharms drugs have patent protection in a total of 23 countries. It's US patent count contributes only to 25.3% of its total global patent coverage. 7 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Alpharma Pharms Drug List

Given below is the complete list of Alpharma Pharms's drugs and the patents protecting them.


1. Embeda

Embeda is protected by 9 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8623418 Pharmaceutical composition 07 Nov, 2029
(5 years from now)
Active
US7815934 Sequestering subunit and related compositions and methods 12 Dec, 2027
(3 years from now)
Active
US7682633 Pharmaceutical composition 19 Jun, 2027
(2 years from now)
Active
US7682634 Pharmaceutical compositions 19 Jun, 2027
(2 years from now)
Active
US8158156 Abuse-deterrent multi-layer pharmaceutical composition comprising an opioid antagonist and an opioid agonist 19 Jun, 2027
(2 years from now)
Active
US8846104 Pharmaceutical compositions for the deterrence and/or prevention of abuse 19 Jun, 2027
(2 years from now)
Active
US8877247 Abuse-deterrent multi-layer pharmaceutical composition comprising an opioid antagonist and an opioid agonist 19 Jun, 2027
(2 years from now)
Active
US8685443 Sequestering subunit and related compositions and methods 03 Jul, 2025
(8 months from now)
Active
US8685444 Sequestering subunit and related compositions and methods 03 Jul, 2025
(8 months from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Embeda's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List